- TGOD recently received an oil sales license from Health Canada for its Ancaster, Ontario, facility
- The company’s state-of-the-art supercritical CO2 extraction system is capable of processing ultra-pure, certified-organic cannabis oils
- TGOD’s Unite Organic Cannabis Oil, derived from a high potency, THC-dominant strain, is expected to be ready to ship in late April 2019
- The company is targeting a potential market in Ontario and Quebec with 21.5 million residents and an estimated value of more than $2.6 billion
Cannabis company The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) has reached another milestone that supports the company’s ambition of becoming the global leader in delivering premium organic cannabis solutions to enhance people’s lives. TGOD recently announced that it is now licensed to sell cannabis oils produced at its Ancaster, Ontario, facility, which previously received an oil production license in April 2018. The oil sales license and production license were both issued by Health Canada, pursuant to the Cannabis Act, according to a news release (http://ibn.fm/58yr1).
“We are pleased to offer TGOD’s medical patients access to new premium certified organic cannabis oils,” Brian Athaide, TGOD CEO, said in the release. “In addition, this step will assist TGOD in transforming our premium quality organic raw material into a variety of higher-margin cannabis products which is core to our business plan, providing us with the opportunity to bring to market innovative and novel products, including beverages and edibles, once regulations permit. Cannabis 2.0 is rapidly approaching, and we will be ready.”
TGOD’s oils will be as close to the original plant as possible, including terpene profiles to realize entourage effects. The process is easily customizable to create full-spectrum, strain-specific oils, as well as oils of varying cannabinoid and terpene concentrations. TGOD Chief Science Officer Dr. Rav Kumar noted in a release that the oil is predominantly a medical product and patients want clean, organic efficacy with safe and easy delivery.
TGOD produces farm grown, organic, pesticide-free medical cannabis using all-natural, organic craft growing principles. These products are laboratory tested to ensure that patients have access to a standardized, safe and consistent product. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis and has positioned itself as one of the highest quality and most cost-efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions (http://ibn.fm/ORqip).
“Through our certified organic product and process we know we are providing patients the best possible experience,” Kumar added. In March, the first group of patients enrolled in the TGOD’s Growers’ Circle received access to purchase the company’s first certified organic cannabis strain through its newly redesigned, award-winning website (http://ibn.fm/WcaTQ).
TGOD’s state-of-the-art supercritical CO2 extraction system is capable of processing ultra-pure, environmentally friendly, organic cannabis oils that are free of toxic solvents. The company’s oil extraction facility was built to current Good Manufacturing Practices (cGMP) specifications, and work is currently underway for European Union GMP (“EU-GMP”) certification, which would allow TGOD to expand distribution of its certified organic cannabis oils beyond Canada and into global markets.
Arcview Market Research, in partnership with BDS Analytics, projects that the edibles market could be worth more than $4.1 billion in Canada and the United States by 2022 (http://ibn.fm/RNW2f). Health Canada is finetuning regulations for sales of cannabis-infused edibles, drinks, extracts and topicals, which are expected to be allowed nationwide no later than October 17, 2019.
For more information, visit the company’s website at www.TGOD.ca
NOTE TO INVESTORS: The latest news and updates relating to TGODF are available in the company’s newsroom at http://ibn.fm/TGODF
About MissionIR
MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
For more information, visit www.MissionIR.com
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
